Advertisement

Topics

Companies Related to "Keytruda Immunotherapy Appears Active Treatment Liver Cancer" [Most Relevant Company Matches] - Page: 5 RSS

04:48 EST 17th February 2019 | BioPortfolio

Here are the most relevant search results for "Keytruda Immunotherapy Appears Active Treatment Liver Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Keytruda Immunotherapy Appears Active Treatment Liver Cancer" Companies 101–125 of 5,900+

Relevant

Genomic Health

Genomic Health gives cancer patients and physicians insight needed to help make quality treatment decisions. GenomicHealth.com is designed to help patients, caregivers and healthcare professionals understand how individualized genomic profiling of tumor tissue may help improve cancer management. The first diagnostic assay developed by Genomic Health — Oncotype DX™ — is a breast cancer test t...


Cyto Pulse Sciences, Inc.

Cyto Pulse Sciences, Inc. is a biomedical device and treatment development company creating innovative technology to produce and deliver new therapeutics for cancer (immunotherapy), infectious diseases (prophylaxis therapy), and genetic defects (gene therapy). Cyto Pulse technology is used in a wide range of fields including monoclonal antibody discovery, ...

NantKwest

NantKwest (Nasdaq:NK) is a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer (NK) cells to treat cancer, infectious diseases and inflammatory diseases. NK cells are the body’s first line of defense due to the innate ability of NK cells to rapidly identify ...


NantKwest, Inc.

NantKwest (Nasdaq:NK) is a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer (NK) cells to treat cancer, infectious diseases and inflammatory diseases. NK cells are the body’s first line of defense due to the innate ability of NK cells to rapidly identify ...

NED Biosystems

Based in Cambridge, Massachusetts, NED Biosystems is a clinical-stage biotech company developing an innovative oral cancer combination treatment. NED Biosystems was founded by Rebecca Lambert, who assembled a team of leading cancer researchers from across the country to develop a drug that simultaneously attacks the key processes that drive cancer survi...

SGX Pharmaceuticals

SGX Pharmaceuticals (formerly Structural GenomiX) is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics.We are developing Troxatyl™, a novel compound that is currently in a pivotal Phase II/III clinical trial for the third-line treatment of Acute Myelogenous Leukemia (AML). We also plan to develop Troxatyl in combination with Ara...

The North Shore-LIJ Cancer Institute

The North Shore-LIJ Cancer Institute is one of the largest cancer providers in the New York metropolitan area. With 200 physicians, the Cancer Institute diagnoses and/or treats more than 16,000 cancer patients each year. Its multidisciplinary teams develop individualized treatment plans that address patients’ physical and emotional needs through 12 di...

WILSHIRE ONCOLOGY MEDICAL GROUP,INC.

Wilshire Oncology has six treatment centers dedicated exclusively to the cancer patient. Since our founding in 1957, we have pioneered community-based cancer care. Our physicians, treatment nurses and support staff will work with you, your primary physician, your hospital and your family to select and deliver the best treatment for you. We also maintain relationships with other oncologists and sub...

Nascent Biotech Inc.

NBI is a biotechnology company developing human Monoclonal Antibodies (mAb’s) for immunotherapy of cancer. Its lead therapeutic candidate, Pritumumab, was the first human antibody ever developed to treat a cancer patient and has been validated in 249 patients in Japan. The company is now developing a new clinical protocol and Initial New Drug (IND) pa...

Agilvax

Agilvax discovers and develops targeted cancer immunotherapies and vaccines with its proprietary virus-like particle (VLP) platform technology. Agilvax’s lead product, AX09, is being developed as an immunotherapy for triple-negative breast cancer (TNBC) by targeting cancer stem cells. TNBC has a high frequency of cancer stem cells, which play a critic...

Agilvax, Inc.

Agilvax discovers and develops targeted cancer immunotherapies and vaccines with its proprietary virus-like particle (VLP) platform technology. Agilvax’s lead product, AX09, is being developed as an immunotherapy for triple-negative breast cancer (TNBC) by targeting cancer stem cells. TNBC has a high frequency of cancer stem cells, which play a critic...

Vaxenta Biotechnologies

Vaxenta is a biotechnology company focused on development of novel immunotherapeutic vaccines for the treatment of cancer. The company’s lead product, XenUvaX, leverages similarities between cancer and pregnancy to selectively target the three essential features of cancer: a) angiogenesis; b) metastasis; and c) immune suppression. Currently the compan...

Rexahn Pharmaceuticals

Rexahn Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of innovative treatments for cancer, central nervous system disorders and other unmet medical needs. Our motto is "Saving Lives Through Innovation," which represents the Company's use of scientific innovation to improve the health and wellness of patients. We develop ...

Trieza Therapeutics, Inc.

Trieza Therapeutics is a Cambridge, MA based biotechnology company building a portfolio of Immuno-modulatory Oncolytic Viruses (IOVs) as therapeutic candidates for cancer immunotherapy.

Puma Biotechnology, Inc.

Puma Biotechnology, Inc. is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those ...

Galil Medical

Ultra-high resolution cryo-surgical device. FDA-approved and effective for prostate cancer, liver cancer and many other applications. System uses needle-probes (1.5mm) to directly freeze localized tissue. 2mm and 3mm probes are available for use in conjunction with IMRI. Galil offers full technical and clinical support for our new-generation cryo system.

Tennessee Cancer Patient Coalition

The Tennessee Cancer Patient Coalition’s mission is to serve as an advocate for cancer patients and their caregivers. The Coalition believes cancer patients should have the opportunity to make informed decisions about their care and have equal access to the most advanced treatment methods available. Proton Therapy is the most advanced form of radiatio...

Actinova AB

Active Biotech develops innovative pharmaceuticals that modulate the body's own immune system. We focus on widespread diseases for which a tremendous need is felt for new and more effective treatments. Our development work has progressed furthest with regard to the treatment of MS and lung, renal and pancreatic cancer.Subsidiary of Actinova Ltd, Cambridge, UK.

Arbios Systems, Inc.

Arbios Systems, Inc. is developing proprietary medical devices and cell-based therapies to enhance the survival of millions of patients each year who experience, or are at risk for, life-threatening episodes of liver failure. The Arbios product candidate portfolio includes the SEPET™ Liver Assist Device, a novel blood purification therapy that provides enhanced “liver dialysis,” and the H...

National Breast Cancer Awareness Month

In the United States, an estimated 192,370 women and 1,910 men will be diagnosed with new cases of breast cancer in 2009. Breast cancer ranks second as a cause of cancer death in women (after lung cancer). Death rates for breast cancer have steadily decreased in women since 1990, due to progress in both earlier detection and improved treatment. The current five-year survival rate for female breast...

ProlX Pharmaceuticals, Corp.

ProlX Pharmaceuticals (ProlX) is a biopharmaceutical company dedicated to the discovery of novel therapeutics for the treatment of cancer. The Company is building a diversified pipeline utilizing a target-directed combinatorial chemistry approach to accelerate the design and development of small molecule drug leads. ProlX’s drug discovery program is focused on targeting redox regulation and sur...

Sirtex Medical

The primary objective of SIRTeX Medical is to research, develop, and commercialise effective treatments for liver cancer using novel small particle technology.

CEL-SCI Corporation CEL-SCI Corporation

CEL-SCI's work is focused on finding the best way to activate the immune system to fight cancer and infectious diseases. Its lead investigational immunotherapy, Multikine* (Leukocyte Interleukin, Injection), is currently being studied in a pivotal Phase 3 clinical trial as a potential neoadjuvant treatment for patients with squamous cell carcinoma of the h...

Scancell Holdings Plc

Scancell is developing novel therapeutic vaccines for the treatment of cancer and infectious diseases based on its groundbreaking ImmunoBody® technology platform. Scancell’s first cancer vaccine SCIB1 is being developed for the treatment of melanoma and has recently entered clinical trials.

ZIOPHARM Oncology

ZIOPHARM Oncology is a biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs to address unmet medical needs. The Company applies new insights from molecular and cancer biology to understand the efficacy and safety limitations of approved and developmental cancer therapies and identifies proprietary and related ...


More From BioPortfolio on "Keytruda Immunotherapy Appears Active Treatment Liver Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks